×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Vivanza Biosciences Limited | NA | NA | NA | NA | 9.48 | |
| Satiate Agri Limited | NA | NA | NA | NA | 8.55 | |
| Ganga Pharmaceuticals Limited | NA | NA | NA | NA | 7.06 | 353.0 |
Vivanza Biosciences Limited, with Security Code 530057, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.0 | 4.8 | 6.0 | 4.9 | 3.9 | 3.4 | 2.3 | 0.4 | 1.6 | 0.8 |
| Expenses | 1.0 | 4.3 | 6.0 | 4.5 | 3.6 | 3.1 | 2.4 | 0.1 | 1.5 | 0.6 |
| Operating Profit | 0.0 | 0.5 | 0.0 | 0.4 | 0.2 | 0.3 | -0.1 | 0.3 | 0.1 | 0.1 |
| OPM % | 1.05% | 10.81% | 0.75% | 8.7% | 6.3% | 7.96% | -5.87% | 74.53% | 6.25% | 15.62% |
| Other Income | 0.2 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.1 | 0.4 | 0.1 | 0.3 | 0.2 | 0.2 | -0.3 | 0.2 | 0.0 | 0.0 |
| Tax % | 0% | 0% | -187.3% | 0% | 0% | 0% | 41.9% | 0% | 0% | 0% |
| Net Profit | 0.1 | 0.4 | -0.1 | 0.3 | 0.2 | 0.2 | -0.4 | 0.2 | 0.0 | 0.0 |
| EPS in Rs | 0.37 | 1.04 | -0.14 | 0.01 | 0.05 | 0.01 | -0.09 | 0.06 | 0.01 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.9 | 8.2 | 9.2 | 7.6 | 6.6 | 4.4 | 2.4 | 3.0 | 1.5 | 0.5 |
| Expenses | 5.3 | 8.2 | 8.6 | 7.3 | 6.3 | 4.6 | 2.1 | 2.9 | 1.4 | 1.4 |
| Operating Profit | 0.6 | 0.0 | 0.6 | 0.3 | 0.3 | -0.1 | 0.4 | 0.1 | 0.1 | -0.9 |
| OPM % | 9.56% | -0.04% | 6.42% | 4.19% | 4.45% | -3.03% | 14.68% | 3.67% | 8.33% | -193.37% |
| Other Income | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit before tax | 0.5 | 0.0 | 0.5 | 0.3 | 0.2 | -0.3 | 0.3 | 0.0 | 0.0 | -1.0 |
| Tax % | 0% | -786.7% | 0% | 0% | 0% | 55.6% | 0% | 0% | 0% | 0% |
| Net Profit | 0.5 | -0.1 | 0.5 | 0.3 | 0.2 | -0.4 | 0.3 | 0.0 | 0.0 | -1.0 |
| EPS in Rs | 1.15 | -0.26 | 0.12 | 0.07 | 0.01 | -0.1 | 0.07 | 0.01 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -21% |
| 3 Years: | -31% |
| TTM: | -80% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -319% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 0% |
| 3 Years: | -47% |
| 1 Year: | -61% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | -5% |
| 3 Years: | -11% |
| TTM: | -73% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | -222% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 0% |
| 3 Years: | -47% |
| 1 Year: | -61% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|